carrito Compra

(0 Productos)

Gastos de envío GRATIS

Solo para España


OXFORD SPECIALIST HANDBOOK IN MYELOPROLIFERATIVE NEOPLASMS

OXFORD SPECIALIST HANDBOOK IN MYELOPROLIFERATIVE NEOPLASMS-9780198744214
  1. Autor:

    Mughal

  2. Isbn:

    9780198744214

  3. Páginas:

    352

  4. Año:

    2020

  5. Edición:

    1

  6. Idioma:

    Ingles

  7. Disponibilidad:

    Próxima publicación

Precio s/iva:

60.00 €

57,00  €
Volver

DESCRIPTION:
Our understanding of myeloproliferative neoplasms (MPN) disorders, a group of clonal haematological malignancies characterized by excessive accumulation of one or more myeloid cell lineages, has grown considerably over the past four decades.

Myeloproliferative Neoplasms offers a detailed evidence-based guide to MPNs in an easily accessible format, structured to facilitate learning specialist information by presenting core information in ""bite size"" chunks.

Each chapter summarises the state-of-the art preclinical and clinical knowledge, and its impact on the clinical management of patients with MPNs. This practical guide, written by experts in the field, is essential reading for oncologists, haematologists, and other health care professionals interested in the field of MPNs.

CONTENTS:
1:History of the myeloproliferative neoplasms
2:Genomic landscape of myeloproliferative neo-plasms
3:Pathogenesis of myeloproliferative neoplasms
4:Haematopathology of myeloproliferative neoplasms
5:Prognostic factors of chronic myeloid leukaemia
6:Molecular risk stratification of Myeloproliferative Neoplasms
7:Chronic myeloid leukaemia
8:Polycythaemia vera
9:Myelofibrosis
10:Essential thrombocythemia
11:Systemic mastocytosis
12:Myelodysplastic syndromes/myeloproliferative neoplasms
13:Eosinophilia-associated myeloproliferative neoplasms
14:Transformation of myeloproliferative neoplasms to acute leukaemia
15:Monitoring efforts in myeloproliferative neoplasms
16:Stem cell transplantation for BCR-ABL1-postive and negative myeloproliferative neoplasms
17:Assessment of disease burden in patients with myeloproliferative neoplasms
18:Clinical trials in bcr-abl1-negative myeloproliferative neo-plasms



Libreria Médica Berri 2020 ®